France· FR:69749991
METOPIMAZINE VIATRIS CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartam
A metopimazine product containing métopimazine, registered in France by VIATRIS SANTE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Price per daily dose
What a daily dose of metopimazine costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- France: $0.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Metopimazine · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- FR France$0.25
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTOPIMAZINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- A04AD05
- ATC class
- Metopimazine
- Defined daily dose
- 15 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930279762plaquette(s) aluminium PVC PVDC de 8 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A04AD05
Metopimazine, as other registers publish it.
- FranceISALIA 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamVENIPHARM
- FranceMETOPIMAZINE ARROW 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamARROW GENERIQUES
- FranceMETOPIMAZINE ARROW CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamARROW GENERIQUES
- FranceMETOPIMAZINE BIOGARAN CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamBIOGARAN
- FranceMETOPIMAZINE VENIPHARM 15 mg, géluleVENIPHARM
- FranceMETOPIMAZINE VENIPHARM 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamVENIPHARM
- FranceVOGALENE 0,1 %, solution buvable en flaconTEVA SANTE
- FranceVOGALENE 10 mg/1 ml, solution injectable en ampouleTEVA SANTE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1863302-575a-46d8-9512-00192b1fe1f8 GET /v1/drugs/e1863302-575a-46d8-9512-00192b1fe1f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69749991",
"date_amm": "2023-09-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉTOPIMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé orodispersible",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about metopimazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.